JP Morgan Maintains Overweight on UiPath, Lowers Price Target to $19
UiPath, Inc. -3.14% Pre
UiPath, Inc. PATH | 12.64 12.64 | -3.14% 0.00% Pre |
JP Morgan analyst Mark Murphy maintains UiPath (NYSE:
PATH) with a Overweight and lowers the price target from $28 to $19.